1Hunt Baker DW,Chin MH,et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult; executive summary[J].J Heart Lung Transplant, 2002,21 (2) : 189-203.
2Hunt Baker DW,Chin MH,et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001, 11,2996-3007.
3Frieder HA, Buckley MM-T. Torasemide-a review of its pharmacology,properties and therapeutic potential. Drugs, 1991,41:81-103.
4Brater DC. Clinical pharmacology of loop diuretics. Drugs, 1991,41:14-22.
5Stauch M, Stiehl L. Controlled, double-blind clinical trial on the efficacy and tolerance of torasemide in comparison with furosemide in patients with congestive heart failure-a multicenter study. In:Kruck F, Mutschler E, Knauf H, eds. Torasemide: clinica
6Sarah F, Fowler Kim M, Murray. Torsemide:A new loop diruetic. Am J Health-Syst Pharm 1995 ,52 ( 15 ): 1771-1780.
7Cosin J, Diez J, TORIC investigators. Torasemide in chronic heart failuro:results of the TORIC study. Eur J Heart Fail 2002,4(4) :507.
8Goodfriend TL, Ball DL, Oelkers W, et al. Torsemide inhibits aldosterone secretion in vitro. Life Sci, 1998,63 ( 3 ): PL45-50.
9Kido H, Ohtaki Y. Torasemide (LUPRAC) :a review of its pharmacological and clinical profile. Nippon Yakurigaku Zasshi,2001,118( 2 ):97-105.
10Brater DC.Clinical pharmacology of loop diuretics[J].Drugs,1991,41 (Suppl 3):14-22.
5Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary[J]. J Heart Lung Transplant, 2002,21(2) : 189-203.
6Fortuno A, Muniz P, Ravassa S, et al. Torasemide inhibits angiotensin Ⅱ-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats [J]. Hypertension, 1999,34 (1) : 138-43.
7Muller K,Gamba G,Jaquet F,et al. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA Ⅱ to Ⅳ-efficacy and quality of life[J]. Eur J Heart Fail,2003,5(6) 793-801.
8Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease [J]. Kidney Int,2003,64(2):632-40.
9Goodfriend TL, Ball DL, Oelkers W, et al. Torasemide inhibits aldosterone secretion in vitro[J]. Life Sci, 1998,63(3) : 45-50.
10Cosin I,Diez J. Torasemide in chronic heart failure[J]. Eur J Heart Fail,2002,4(4) :507-513.
